All Events

Filter by

Event Date

Filter by Event Date

Done
viles of blood
September 22 - 23, 2016
6701 Rockledge Drive, (Conference Room 9100/9104)
Bethesda, MD 20892
Recent advances in omic tools-(genomics, proteomics, transcriptomics and metabolomics and their critical metabolites)-have created a set of tools box that can use small blood volumes for ultra- sensitive detection of key biomarkers that will allow creation of pathophysiological molecular finger prints.
Building 35A, the Porter Neuroscience Center
National Institutes of Health (NIH), Bethesda, Maryland
The 269th meeting of the National Heart, Lung, and Blood Advisory Council (NHLBAC) was convened on Tuesday, September 20, 2016, in Building 35A, the Porter Neuroscience Center, National Institutes of Health (NIH), Bethesda, Maryland and included the Advisory Council’s Board of External Experts (BEE) Working Group members. Strategic Visioning working groups met in the morning, and the Council meeting began at 12:30 p.m. and ended at 3:41 p.m. Dr. Gary H. Gibbons, Director of the National Heart, Lung, and Blood Institute (NHLBI), presided as Chair.
6701 Rockledge Drive, (Conference Room 9100/9104)
Bethesda, MD 20892
This September 2016 workshop considered the gaps in our knowledge and technology that are barriers to our understanding of the underlying biologies that may lead to effective new treatments for late stage erythroid maturation defects.
National Institutes of Health (NIH)
Bethesda, Maryland
The 268th meeting of the National Heart, Lung, and Blood Advisory Council (NHLBAC) was convened on Tuesday, August 30, 2016, in Rockledge II, Conference Room 9100/9104 at the National Institutes of Health (NIH), Bethesda, Maryland. The meeting was closed to the public from 1:08 p.m. until adjournment at 1:38 p.m. Dr. Gary H. Gibbons, Director of the National Heart, Lung, and Blood Institute (NHLBI), presided as Chair.
scientist holding test tubes
August 15 - 17, 2016
NIH Clinical Center
Building 10
The NHLBI Annual Sickle Cell Disease Clinical Research Meetings provide a yearly forum for investigators, practitioners, and interested health care providers to discuss the progress of ongoing clinical trials, hear presentations about new developments in scientific and clinical aspects of SCD, and interact with other investigators and NHLBI Program Staff.